SLAS Europe 2025
At this year’s SLAS Europe 2025, innovation, automation, and Life-Science excellence took center stage and EFEVRE TECH LTD was proudly among the pioneers leading the way. Our very own Robotic Software Engineer, Marios Konstantinou, represented the company with a powerful scientific poster presentation, introducing the world to AMGEL4TT; our next-generation modular automation workstation, and its integration software with the transformative VITALE software platform.
​
This momentous event not only showcased EFEVRE TECH’s technological leadership, but also significantly propelled the development and visibility of the VITALE project across the European scientific and clinical research communities.
VITALE: A Platform Designed to Revolutionize Genomic Workflows
At the heart of the poster presentation was the VITALE software as well as the AMGEL4TT robotic automation platform, engineered to automate and streamline high-throughput EDTA blood processing, DNA extraction, and next-generation sequencing (NGS). The fully modular and scalable workstation reduces human error and operator dependency while enhancing reproducibility and compliance in both research and diagnostic environments.
​
From barcode scanning and fluorometric quantification to cloud-hosted LIMS integration and real-time data tracking, VITALE is designed to offer remote access with true walk-away automation, supporting over 24 hours of uninterrupted processing. This poster drew attention not only for its technical depth but also for the bold vision it offers: future-proof molecular workflows.
Boosting VITALE: From Software Concept to Clinical Enabler
SLAS Europe 2025 served as a powerful launchpad for VITALE, EFEVRE TECH’s software interface that empowers Life-Science researchers to customize protocols dynamically without needing hardware reconfiguration. Marios Konstantinou’s presentation ignited cross-disciplinary conversations about the value of flexible automation, and how the integration of VITALE into AMGEL4TT positions it as a game-changer in life science laboratories.
​
This exposure triggered interest from potential collaborators and early adopters, affirming the relevance of VITALE in today’s fast-evolving biomedical landscape. The presentation helped validate our approach to modular automation and intelligent software control, an approach that’s now drawing attention across Europe’s research and diagnostic sectors.
A Resounding Success for EFEVRE TECH
Our presence at SLAS Europe 2025 wasn’t just a showcase, it was a strategic catalyst. The insights and connections gained at this event have helped us refine user feedback loops, attract new collaborators, and better position the VITALE-AMGEL4TT duo for commercialization and clinical piloting.
​
The response to our poster entitled "Versatile Automation for IVDR Method Development in CH Detection" was overwhelmingly positive. Attendees recognized its alignment with the urgent clinical need for scalable Clonal Hematopoiesis (CH) detection, especially in the context of acute myeloid leukemia (AML) and cardiovascular risk stratification.
Looking Ahead: Building Scientific Trust, One Connection at a Time
This milestone event marked a turning point for the proposed VITALE project. By engaging with Europe’s leading scientists, innovators, and thought leaders, we are now better equipped to move from TRL 4 to TRL 6, expanding clinical testing while ensuring regulatory alignment and scientific robustness. SLAS Europe 2025 reaffirmed our belief: the future of genomic medicine belongs to platforms that combine automation, adaptability, and intelligence.
​
Stay tuned as we unveil the next chapter of VITALE — and thank you to everyone who visited our poster presentation!
​
The Project with the proposal number ENTERPRISES/0223/Sub-Call1/105 and project acronym VITALE is funded by the European Union Recovery and Resilience Facility of the NextGenerationEU instrument, through the Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation.
